Skip to content

Clinical trials

Sleep Initiation and Maintenance Disorders trials in China with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sleep Initiation and Maintenance Disorders Phase: Not applicable Country / region: China Clear all

111 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20142
20151
20161
20175
20183
20193
20203
20219
202211
202317
202431
20256
202617

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Unknown status29
Recruiting26
Not yet recruiting8
Active, not recruiting5
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Xuanwu Hospital, Beijing10
Jiangsu Province Nanjing Brain Hospital4
Nanfang Hospital, Southern Medical University4
Shanghai Mental Health Center4
Beijing Sport University3
Peking University3
Peking University First Hospital3
The University of Hong Kong3
Xijing Hospital3
Central South University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sleep Initiation and Maintenance Disorders111
Anxiety Disorders9
Sleep Wake Disorders7
Parasomnias4
Breast Neoplasms3
Cognitive Dysfunction3
Fatigue3
Ischemic Stroke3
Hypertension2
Neoplasms2

Trials

Showing 1 to 25 of 111. Each trial links to its page on Pharma Observatory.

11 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.